Trials / Completed
CompletedNCT05773027
Integrated Alcohol and Sexual Assault Intervention for College Men
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- Lifespan · Academic / Other
- Sex
- Male
- Age
- 18 Years – 22 Years
- Healthy volunteers
- Accepted
Summary
This research will evaluate a new intervention that integrates evidence-based alcohol intervention strategies and promising sexual assault prevention strategies with the goal of decreasing sexual aggression among men who report heavy drinking; a particularly high risk group. Specifically, this study will conduct a randomized controlled pilot trial with college men who report heavy drinking to demonstrate the feasibility and acceptability of the proposed intervention. The main questions the study will answer are: 1) what is the feasibility of the recruitment plans, research design, intervention training methods, and delivery of the program?; and 2) does the intervention, relative to a mindfulness-based control condition, produce reductions in the quantity and frequency of alcohol use, perpetration of sexual aggression, and attitudes associated with sexual aggression over the 2- and 6-month follow-up. Follow-up assessments are completed at 2- and 6-months following the program. The intervention is compared to the mindfulness-based control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SAFE | SAFE includes a motivational interviewing session addressing alcohol use and risk for sexual aggression, a workshop addressing alcohol use and sexual aggression, and a booster session review. |
| BEHAVIORAL | Mindfulness-Based Control Condition | The program includes the same amount of contacts as SAFE, including an individual session focused on mindfulness and stress, a group session, and a booster session review. |
Timeline
- Start date
- 2013-10-17
- Primary completion
- 2017-12-13
- Completion
- 2017-12-13
- First posted
- 2023-03-17
- Last updated
- 2023-03-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05773027. Inclusion in this directory is not an endorsement.